Biotech companies in the United States by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 15 biotech companies in the United States ranked by P/S ratio, at 3.7, followed by Neurocrine Biosciences (5.5) and Amgen (6.5). Figures as of 20 Nov 2026, 11:15 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
15
Lowest
Biogen3.7
Median
14.7
Combined market value
CHF 618.5B
Countries
1
Not ranked
5no P/S ratio on file

Market values as of .

United States
All sectors
Biotech
CHF
Clear filters
Biotech companies in the United States by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.7CHF 30.7BCHF 207.99 1.70% down 49% up United States
2Neurocrine BiosciencesNBIX · Health Care5.5CHF 13.3BCHF 131.79 3.85% down 17% up United States
3AmgenAMGN · Health Care6.5CHF 199.8BCHF 369.32 1.14% down 32% up United States
4ExelixisEXEL · Health Care6.9CHF 13.5BCHF 55.40 3.60% down 63% up United States
5Gilead SciencesGILD · Health Care7.0CHF 173.8BCHF 140.16 1.45% down 35% up United States
6Halozyme TherapeuticsHALO · Health Care7.6CHF 8.9BCHF 78.31 2.88% down 39% up United States
7Bio-TechneTECH · Health Care9.4CHF 9.6BCHF 61.19 0.07% down 24% up United States
8RepligenRGEN · Health Care14.7CHF 9.2BCHF 143.32 1.38% down 12% up United States
9Adaptive BiotechnologiesADPT · Health Care16.4CHF 3.8BCHF 23.61 1.44% down 74% up United States
10Twist BioscienceTWST · Health Care20.2CHF 6.4BCHF 93.94 4.07% down 346% up United States
11Krystal BiotechKRYS · Health Care24.1CHF 7.9BCHF 265.80 0.15% up 54% up United States
12ModernaMRNA · Health Care41.5CHF 67.9BCHF 167.76 1.29% up 780% up United States
13ImmunityBioIBRX · Health Care61.7CHF 5.9BCHF 5.53 1.94% down 232% up United States
14Kymera TherapeuticsKYMR · Health Care260CHF 8.6BCHF 100.48 1.44% down 87% up United States
15CG OncologyCGON · Health Care1811CHF 6.2BCHF 68.93 2.38% up 97% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8416 CHF). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies in the United States have the lowest P/S ratio?

Biogen (3.7), Neurocrine Biosciences (5.5) and Amgen (6.5) have the lowest P/S ratio of the 15 biotech companies in the United States ranked here as of 20 Nov 2026, 11:15 UTC.

How many biotech companies in the United States are in this ranking?

15 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 15 biotech companies in the United States ranked by P/S ratio have a combined market value of CHF 618.5B as of 20 Nov 2026, 11:15 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies in the United States by P/S ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.